Sponsor & Exhibitor

We are focused on creating genuinely innovative medicines and improving access to them. In this way, we deliver the greatest benefit to patients, healthcare systems and societies globally. We have three priorities designed to deliver our growth through innovation strategy.

Accelerate Innovative Science: Accelerating the next wave of new molecular entities, building our capabilities in immunology and rare diseases, pursuing new scientific modalities and driving R&D productivity

Deliver Growth and Therapy Area Leadership: Meeting our growth and profitability goals through successful innovation and commercial excellence, as well as completing the Alexion acquisition

Be a Great Place to Work: Contributing to the enterprise and to society, with a focus on inclusion and diversity, lifelong learning, improving access to healthcare, environmental protection, and ethics and transparency, as well as delivering our Ambition Zero Carbon program.

Inspired by our Values and what science can do, we are focused on accelerating the delivery of life-changing medicines that create enduring value for patients and society.
We are committed to operating in a way that recognizes the interconnection between business growth, the needs of society and the limitations of our planet.

GSK is a science-led global healthcare company on a mission to research, develop, manufacture and market innovative medicines and vaccines to unite science, technology and talent to get ahead of disease together.

GSK has a 300-year global legacy, and for more than 65 years has been operating, employing and investing in the Gulf Cooperation Council region.

We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance. We are a company where outstanding people can thrive. For more info, please visit Home | GSK.

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in the two business units Human Pharma and Animal Health.

Chiesi is an international group based in Parma, research-oriented, with over 85 years of experience, present in 30 countries. The Chiesi Group researches, develops and markets innovative drugs in three specific areas: AIR (products and services in the respiratory field, from infants to adults), RARE (innovative solutions and personalized services to improve the quality of life of patients with rare and ultra-rare diseases) and CARE (products and services to support specialist care, personal care and well-being).

Since 2019 Chiesi has been the largest pharmaceutical group in the world certified B Corp, while, in 2018, Chiesi changed its legal status to a Benefit Company, realizing the desire to measure its impact on society and the environment, combining the need to generate value for the business to acting as a positive force for the community in which we live.

The Group's Research and Development is based in Parma and integrates with six other major research centers in France, the United States, Canada, China, the United Kingdom and Sweden, to promote its preclinical, clinical and regulatory programs. Its production activity, on the other hand, takes place in three plants located in Parma (Italy), Blois (France) and Santana de Parnaiba (Brazil).

MDC Care Medical Trading LLC | Elevating Healthcare Since 2007 in the United Arab Emirates, Our mission remains to cater to UAE’s growing healthcare industry, and supply markets with world-class medical technology . We are a trusted name in delivering innovative and reliable healthcare solutions with a steadfast commitment to innovation, quality, and affordability.

Our mission is to deliver comprehensive healthcare solutions that enhance patient care and support medical professionals across the region. Our products are carefully selected to ensure optimal performance, safety and value.

Our Specialized areas include respiratory care, physiotherapy and rehabilitation, diagnostic and medical equipment, mobility aids, lifestyle wellness, and surgical products. Our customer-centric approach, combined with strong partnerships and a dedicated team of professionals, enables us to provide unmatched service and support to hospitals, clinics, and healthcare providers.

Our unbeatable presence in the market over the past 17+ years has made us a powerful partner among the leading scientific and healthcare brands, Our strength lies in our ability to adapt quickly to market demands, backed by a dedicated team and strong industry partnerships.

At MDC Care, we don’t just supply products—we deliver confidence, care, and continuity to healthcare providers across the UAE and beyond.

Johnson & Johnson is a global healthcare leader, committed to solving the toughest health challenges and transforming lives through research, development, manufacture and distribution of innovative medicines and medical technologies. The company’s Innovative Medicine business advances breakthrough science and develops transformational treatments in areas like oncology, immunology, neuroscience, and cardiopulmonary. In MedTech, the company is focused on developing and delivering cardiovascular, orthopaedics, surgery, and vision solutions. Visit jnj.com to learn more.